CYP19A1 and breast carcinoma: The direct inhibition of estrogen synthesis targeting aromatase inhibition is considered to be an effective strategy towards breast cancer treatment (Altundag and Ibrahim, 2006[1]; Brueggemeier et al., 2005[5]; Favia et al., 2013[12]).